Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)

CNY 7.47

(-0.53%)

Market Cap (In CNY)

2.75 Billion

Revenue (In CNY)

644.97 Million

Net Income (In CNY)

25.4 Million

Avg. Volume

5.37 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5.9-14.04
PE
-
EPS
-
Beta Value
0.465
ISIN
CNE100001TG0
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Hongsheng Xu
Employee Count
-
Website
https://www.zjspas.com
Ipo Date
2014-07-02
Details
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antipyretic and analgesic, antibacterial anti-inflammatory, endocrine, auxiliary, cardiovascular, detoxification, diuretic row stone, gynecology, and infusion categories. It offers its products in injections, oral solutions, eye drops, tablets, capsules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.